EXOZYMES INC. Operating Cash Flow
EXOZYMES INC. (EXOZ) reported Operating Cash Flow of -$3.16 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- EXOZYMES INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$1.64M.
- EXOZYMES INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$1.52M.
- EXOZYMES INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$1.97M.
- EXOZYMES INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$1.86M.
- EXOZYMES INC. net cash provided by (used in) operating activities for fiscal 2025 was -$6.50M.
- EXOZYMES INC. net cash provided by (used in) operating activities for fiscal 2024 was -$8.51M.
- EXOZYMES INC. net cash provided by (used in) operating activities for fiscal 2023 was -$1.18M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$3.16M 10-Q · filed 2026-08-13 | -$5.14M derived: sum of 3 quarters · filed 2026-08-13 | -$7.00M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$1.52M 10-Q · filed 2026-05-14 | -$3.50M derived: sum of 2 quarters · filed 2026-05-14 | -$5.35M derived: sum of 3 quarters · filed 2026-05-14 | -$6.89M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$3.83M derived: sum of 2 quarters · filed 2026-03-30 | -$5.37M derived: sum of 3 quarters · filed 2026-08-13 | -$6.50M 10-K · filed 2026-03-30 |
| 2025-09-30 | -$1.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$3.39M derived: sum of 2 quarters · filed 2026-08-13 | -$4.53M 10-Q · filed 2025-11-13 | -$10.24M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$1.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$2.67M 10-Q · filed 2026-08-13 | -$8.38M derived: sum of 3 quarters · filed 2026-08-13 | -$8.92M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$1.13M 10-Q · filed 2026-05-14 | -$6.84M derived: sum of 2 quarters · filed 2026-05-14 | -$7.38M derived: sum of 3 quarters · filed 2026-05-14 | -$9.92M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$5.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$6.25M derived: sum of 2 quarters · filed 2026-03-30 | -$8.79M derived: sum of 3 quarters · filed 2026-03-30 | -$8.51M 10-K · filed 2026-03-30 |
| 2024-09-30 | -$541.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$3.08M derived: sum of 2 quarters · filed 2025-11-13 | -$2.80M 10-Q · filed 2025-11-13 | -$3.58M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$2.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$2.26M 10-Q · filed 2025-08-12 | -$3.04M derived: sum of 3 quarters · filed 2025-08-12 | |
| 2024-03-31 | $281.20K 10-Q · filed 2025-05-12 | -$502.08K derived: sum of 2 quarters · filed 2025-05-12 | ||
| 2023-12-31 | -$783.28K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$1.18M 10-K · filed 2025-03-31 | ||
| 2023-09-30 | -$397.59K 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |